Status:

COMPLETED

Non-inferiority Comparison of Efficacy and Safety of Penciclovir 10mg/g to Acyclovir 50mg/g in the Treatment of Recurrent Herpes Labialis

Lead Sponsor:

EMS

Conditions:

Herpes Labialis

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Herpes labialis is the most common recurrent manifestation of herpes simplex. The purpose of this study is to check the non-inferiority efficacy and safety of penciclovir 10mg/g as treatment for Herpe...

Detailed Description

Study design: • Double blinded non-inferiority prospective parallel-group, intend to treat trial. Study design: * Experiment duration: 10 days * 3 visits (days 1,5 and 10) * Erythema, papule, vesic...

Eligibility Criteria

Inclusion

  • Patients must be able to understand the study procedures agree to participate and give written consent.
  • Patients with clinical diagnosis of recurrent herpes labialis and are in the prodromal period (stinging, itching, burning and erythema) at the onset of signs / symptoms in the last 12-24 hours;
  • No history of reaction to topical products;

Exclusion

  • Pregnancy or risk of pregnancy.
  • Lactation
  • Use of anti-inflammatory or immunosuppressive drugs (last 30 days prior to the study.)
  • Sunlight over exposure in the last 15 days.
  • Any pathology or past medical condition that can interfere with this protocol.
  • AINH use, hormonal anti-inflammatory, analgesic and immunosuppressive drugs (in the last 30 days and during the study);
  • Patients with immunodeficiency and/or immunosuppressive disease;
  • Sunlight exposure in the last 15 days;
  • Hypersensitivity to components of the formula;
  • Other conditions deemed reasonable by the medical investigator as to the disqualification of the individual from study participation.

Key Trial Info

Start Date :

February 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2012

Estimated Enrollment :

76 Patients enrolled

Trial Details

Trial ID

NCT01257074

Start Date

February 1 2012

End Date

October 1 2012

Last Update

March 4 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Flavia Addor

São Paulo, São Paulo, Brazil

Non-inferiority Comparison of Efficacy and Safety of Penciclovir 10mg/g to Acyclovir 50mg/g in the Treatment of Recurrent Herpes Labialis | DecenTrialz